Biosimilars Policy Roundup for March 2023—Podcast Edition

On this episode of Not So Different, we discuss some of the global biosimilar policy news that came out during the month of March, including a new bill in Congress and 2 Canadian jurisdictions implementing switching policies.

Show notes

Canadian Province Newfoundland and Labrador Adds Biosimilar Switching Policy

Yukon Becomes Tenth Canadian Jurisdiction to Add Biosimilars Switching Policy

Policy Recommendations for Improving Biosimilar Uptake in Belgium

Researchers Recommend Improvements for China’s Biosimilar Regulatory Policies

Dr Ivo Abraham Column: The 2022 WHO Biosimilar Guidelines—Loosening the Reins or Changing the Track? Part 2

The Increasing Access to Biosimilars Act of 2023 Introduced to Congress

Published Data Coupled With Real-world Evidence Show Safety of Biosimilar-to-Biosimilar Switching

Uptake Barriers Will Deter Future Competitors From Investing in Biosimilars, Julie Reed Warns